Abstract: A shock wave and/or ultrasound therapy system has an ultrasound and/or shockwave source with an ultrasonic transducer for ultrasonic imaging or an X-ray imaging system which is configured for providing a video signal, and which is coupled to a video processor. The video processor includes a neural network and is configured for detecting in the video signal at least one kidney stone and/or at least one kidney itself, which are marked in the video signal and displayed on a display.

Abstract: Various embodiments of the present disclosure relate to systems and apparatus for oral interfaces. According to particular embodiments, an oral interface comprises a body comprising a flow channel extending through the body from a first opening to a second opening. A lip commissure hook extends from a first end of the body in a curved configuration, and an intraoral portion extends from the lip commissure hook to form a gap between the intraoral portion and the body. An outer mandibular contact extends from the body. The flow channel extends through the lip commissure hook and the intraoral portion to the first opening and to a second opening located at a second end of the body. The intraoral portion and the outer mandibular contact are configured to apply frictional forces against the user's mandible and cheek to stabilize the oral interface upon the user.

Abstract: A RNA vaccine containing a RNA molecule encoding an allergen or derivative thereof, in which the allergen is an allergen of Alnus glutinosa, Alternaria alternata, Ambrosia artemisiifolia, Apium graveolens, Arachis hypogaea, Betula verrucosa, Carpinus betulus, Castanea sativa, Cladosporium herbarum, Corylus avellana, Cryptomeria japonica, Cyprinus carpio, Daucus carota, Dermatophagoides pteronyssinus, Fagus sylvatica, Felis domesticus, Hevea brasiliensis, Juniperus ashei, Malus domestica, Quercus alba or Phleum pratense.

Abstract: A vaccine preparation comprising an antigen for use in the prophylactic or therapeutic treatment of a subject by intradermal administration through laser-generated micropores, wherein the antigen is linked to a binder of a dermal migratory antigen-presenting cell (APC); and a pharmaceutical preparation comprising an active substance for use in the prophylactic or therapeutic treatment of a subject by intradermal administration through laser-generated micropores, for regional delivery to a target location. The invention further relates to the laser-assisted intradermal administration of antigens accompanied by repeated chemotherapy.

Abstract: Various embodiments of the present disclosure relate to systems and apparatus for oral interfaces. According to particular embodiments, an oral interface comprises a body comprising a flow channel extending through the body from a first opening to a second opening. A lip commissure hook extends from a first end of the body in a curved configuration, and an intraoral portion extends from the lip commissure hook to form a gap between the intraoral portion and the body. An outer mandibular contact extends from the body. The flow channel extends through the lip commissure hook and the intraoral portion to the first opening and to a second opening located at a second end of the body. The intraoral portion and the outer mandibular contact are configured to apply frictional forces against the user's mandible and cheek to stabilize the oral interface upon the user.

Abstract: The invention describes powders for use in the production of spatial structures, i.e. molded bodies, using layer build-up methods, as well as methods for their efficient production. The powders have the special feature that they have good flow behavior, for one thing, and at the same time, have such a composition that the molded body that can be produced with the powder, using rapid prototyping, has significantly improved mechanical and/or thermal properties. According to a particularly advantageous embodiment, the powder has a first component that is present in the form of essentially spherical powder particles, which is formed by a matrix material, and at least one further component in the form of stiffening and/or reinforcing fibers, which are preferably embedded in the matrix material.

Abstract: A RNA vaccine containing a RNA molecule encoding an allergen or derivative thereof, in which the allergen is an allergen of Alnus glutinosa, Alternaria alternata, Ambrosia artemisiifolia, Apium graveolens, Arachis hypogaea, Betula verrucosa, Carpinus betulus, Castanea sativa, Cladosporium herbarum, Corylus avellana, Cryptomeria japonica, Cyprinus carpio, Daucus carota, Dermatophagoides pteronyssinus, Fagus sylvatica, Felis domesticus, Hevea brasiliensis, Juniperus ashei, Malus domestica, Quercus alba or Phleum pratense.

Abstract: The invention describes powders for use in the production of spatial structures, i.e. molded bodies, using layer build-up methods, as well as methods for their efficient production. The powders have the special feature that they have good flow behavior, for one thing, and at the same time, have such a composition that the molded body that can be produced with the powder, using rapid prototyping, has significantly improved mechanical and/or thermal properties. According to a particularly advantageous embodiment, the powder has a first component that is present in the form of essentially spherical powder particles, which is formed by a matrix material, and at least one further component in the form of stiffening and/or reinforcing fibers, which are preferably embedded in the matrix material.

Abstract: A RNA vaccine containing a RNA molecule encoding an allergen or derivative thereof, in which the allergen is an allergen of Alnus glutinosa, Alternaria alternata, Ambrosia artemisiifolia, Apium graveolens, Arachis hypogaea, Betula verrucosa, Carpinus betulus, Castanea sativa, Cladosporium herbarum, Corylus avellana, Cryptomeria japonica, Cyprinus carpio, Daucus carota, Dermatophagoides pteronyssinus, Fagus sylvatica, Felis domesticus, Hevea brasiliensis, Juniperus ashei, Malus domestica, Quercus alba or Phleum pratense.

Abstract: The invention describes powders for use in the production of spatial structures, i.e. molded bodies, using layer build-up methods, as well as methods for their efficient production. The powders have the special feature that they have good flow behavior, for one thing, and at the same time, have such a composition that the molded body that can be produced with the powder, using rapid prototyping, has significantly improved mechanical and/or thermal properties. According to a particularly advantageous embodiment, the powder has a first component that is present in the form of essentially spherical powder particles, which is formed by a matrix material, and at least one further component in the form of stiffening and/or reinforcing fibers, which are preferably embedded in the matrix material.

Abstract: Described are powders for use in the production of three-dimensional structures or molded bodies by means of layered manufacturing methods, and methods for the economical production thereof. The powders have the particularity that they have a good flow behavior, on the one hand, and that they are simultaneously configured such that the molded body produced with the powder in rapid prototyping has substantially improved mechanical and/or thermal characteristics. In accordance with a particularly advantageous embodiment, the powder comprises a first fraction that is present in the form of substantially spherical powder particles and that is formed by a matrix material, and at least one further fraction in the form of strengthening and/or reinforcing fibers that are preferably embedded into the matrix material.

Abstract: The present invention relates to an RNA vaccine comprising an RNA molecule encoding an allergen or derivative thereof and uses thereof.

Abstract: The invention describes powders for use in the production of spatial structures, i.e. molded bodies, using layer build-up methods, as well as methods for their efficient production. The powders have the special feature that they have good flow behavior, for one thing, and at the same time, have such a composition that the molded body that can be produced with the powder, using rapid prototyping, has significantly improved mechanical and/or thermal properties. According to a particularly advantageous embodiment, the powder has a first component that is present in the form of essentially spherical powder particles, which is formed by a matrix material, and at least one further component in the form of stiffening and/or reinforcing fibers, which are preferably embedded in the matrix material.

Abstract: The present invention relates to substituted cyclopentanone derivatives and their use as fragrance chemicals suitable for incorporation in fine fragrances, cosmetics, toiletries and related applications.